Illness finder is a diagnostic medicine tool for educational purpose that looks up your patients' health conditions or symptoms and diagnosis and find diseases or illnesses based on chosen gender, age, risk factors, illness, signs, symptoms and prevalence. Illnessfinder is inspired by Evidence based medicine (EMB) and healthcare that aims to apply the best (most reliable) knowledge that is available at decision time. Illnessfinder aims to free up time for the therapeutic dialogue and ensure quality at the evidence based practice, uniting proven medical findings and clinical evidence with systematised data technology.
Enter a medical term  
Lymphoma, Non-HodgkinLegal notice  


Other terms
Lymphoma, Non Hodgkin,Lymphoma, Non-Hodgkin's,Lymphoma, Non Hodgkin's,Lymphoma, Non-Hodgkins,Lymphoma, Non Hodgkins,Non-Hodgkins Lymphoma,Lymphoma, Nonhodgkin's,Lymphoma, Nonhodgkin,Nonhodgkin's Lymphoma,Lymphoma, Nonhodgkins,Nonhodgkins Lymphoma,Diffuse Small Cleaved-Cell Lymphoma,Diffuse Small Cleaved Cell Lymphoma,Lymphoma, Small Cleaved-Cell, Diffuse,Non-Hodgkin Lymphoma,Non Hodgkin Lymphoma,Non-Hodgkin's Lymphoma,Non Hodgkin's Lymphoma,Small Cleaved-Cell Lymphoma, Diffuse,Small Cleaved Cell Lymphoma, Diffuse,Lymphoma, Atypical Diffuse Small Lymphoid,Lymphoma, Small Cleaved Cell, Diffuse,Lymphoma, High-Grade,High-Grade Lymphoma,High-Grade Lymphomas,Lymphoma, High Grade,Lymphomas, High-Grade,Lymphoma, Intermediate-Grade,Intermediate-Grade Lymphoma,Intermediate-Grade Lymphomas,Lymphoma, Intermediate Grade,Lymphomas, Intermediate-Grade,Reticulum-Cell Sarcoma,Reticulum Cell Sarcoma,Reticulum-Cell Sarcomas,Sarcomas, Reticulum-Cell,Sarcoma, Reticulum-Cell,Sarcoma, Reticulum Cell,Reticulosarcoma,Reticulosarcomas,Lymphoma, Mixed-Cell,Lymphoma, Mixed Cell,Lymphoma, Mixed Lymphocytic-Histiocytic,Lymphocytic-Histiocytic Lymphoma, Mixed,Lymphocytic-Histiocytic Lymphomas, Mixed,Lymphoma, Mixed Lymphocytic Histiocytic,Lymphomas, Mixed Lymphocytic-Histiocytic,Mixed Lymphocytic-Histiocytic Lymphoma,Mixed Lymphocytic-Histiocytic Lymphomas,Mixed-Cell Lymphoma,Lymphomas, Mixed-Cell,Mixed Cell Lymphoma,Mixed-Cell Lymphomas,Lymphoma, Mixed,Lymphomas, Mixed,Mixed Lymphoma,Mixed Lymphomas,Lymphoma, Mixed-Cell, Diffuse,Lymphoma, Small and Large Cleaved-Cell, Diffuse,Mixed Small and Large Cell Lymphoma, Diffuse,Mixed-Cell Lymphoma, Diffuse,Mixed Cell Lymphoma, Diffuse,Lymphoma, Mixed Cell, Diffuse,Diffuse Mixed Small and Large Cell Lymphoma,Diffuse Mixed-Cell Lymphoma,Diffuse Mixed Cell Lymphoma,Diffuse Mixed-Cell Lymphomas,Lymphoma, Diffuse Mixed-Cell,Lymphomas, Diffuse Mixed-Cell,Mixed-Cell Lymphomas, Diffuse,Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic,Lymphoma, Mixed Small and Large Cell, Diffuse,Lymphoma, Small Noncleaved-Cell,Lymphoma, Small Noncleaved Cell,Small Non-Cleaved-Cell Lymphoma,Small Non Cleaved Cell Lymphoma,Lymphoma, Small Non-Cleaved-Cell,Lymphoma, Small Non Cleaved Cell,Lymphomas, Small Non-Cleaved-Cell,Non-Cleaved-Cell Lymphoma, Small,Non-Cleaved-Cell Lymphomas, Small,Small Non-Cleaved-Cell Lymphomas,Lymphoma, Undifferentiated, Diffuse,Small Noncleaved-Cell Lymphoma,Lymphomas, Small Noncleaved-Cell,Noncleaved-Cell Lymphoma, Small,Noncleaved-Cell Lymphomas, Small,Small Noncleaved Cell Lymphoma,Small Noncleaved-Cell Lymphomas,Diffuse Undifferentiated Lymphoma,Diffuse Undifferentiated Lymphomas,Lymphoma, Diffuse Undifferentiated,Lymphomas, Diffuse Undifferentiated,Undifferentiated Lymphoma, Diffuse,Undifferentiated Lymphomas, Diffuse,Lymphoma, Undifferentiated,Undifferentiated Lymphoma,Lymphomas, Undifferentiated,Undifferentiated Lymphomas,Lymphoma, Pleomorphic,Lymphomas, Pleomorphic,Pleomorphic Lymphoma,Pleomorphic Lymphomas,Lymphoma, Diffuse,Diffuse Lymphoma,Diffuse Lymphomas,Lymphomas, Diffuse,Lymphosarcoma,Lymphosarcomas,Sarcoma, Lymphatic,Lymphatic Sarcoma,Lymphatic Sarcomas,Sarcomas, Lymphatic,Lymphoma, Low-Grade,Low-Grade Lymphoma,Low-Grade Lymphomas,Lymphoma, Low Grade,Lymphomas, Low-Grade

Description
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.



Pervious tree


Next tree


Other locations in tree


Legal notice
The U.S. National Library of Medicine is the creator, maintainer, and provider of the data above.
The version of the data is 2010 MeSH. Last reviewed April 26, 2010. No modification has been made in the content of the file.
Neither the United States Government, nor any of its agencies, contractors, subcontractors or employees makes any warranties, expressed or implied, with respect to data contained in the database, and, furthermore, assumes no legal liability for any party's use, or the results of such use, of any part of the database.
You will not assert any proprietary rights to any portion of the database, or represent the database or any part thereof to anyone as other than a United States Government database.
The MeSH data carry an international copyright outside the United States, its Territories or Possessions. These terms and conditions are in effect as long as the user retains any of the MeSH data obtained from this site.